Načítá se...
Factors associated with sepsis risk in immune-mediated inflammatory diseases receiving tumor necrosis factor inhibitors: a nationwide study
BACKGROUND: Risk factors for sepsis have not been assessed in patients receiving tumor necrosis factor-alpha inhibitors (TNFi) for immune-mediated inflammatory diseases (IMIDs) who are vulnerable to serious/hospitalized infections. METHODS: Data from 2003–2017 were obtained from Taiwan’s National He...
Uloženo v:
| Vydáno v: | Ther Adv Musculoskelet Dis |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7298427/ https://ncbi.nlm.nih.gov/pubmed/32595776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20929208 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|